浆细胞白血病
浆细胞失调
精神障碍
多发性骨髓瘤
医学
免疫分型
等离子体电池
浆细胞肿瘤
血清蛋白电泳
浆细胞骨髓瘤
病理
内科学
流式细胞术
胃肠病学
免疫学
免疫球蛋白轻链
浆细胞瘤
单克隆
抗体
单克隆抗体
作者
Prithal Gangadhar,Zulfikar Ahmed,Muktha R Pai,I Sandhya
标识
DOI:10.4103/0377-4929.191818
摘要
Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma accounting for 2-3% of all plasma cell dyscrasias characterized by the presence of circulating plasma cells. The diagnosis is based on the % (≥20%) and absolute number (≥2x10 9 /L) of plasma cells in the peripheral blood. The incidence of primary PCL (pPCL) is very rare and reported to occur in <1 in a million. It is classified as either pPCL occurring at diagnosis or as secondary PCL in patients with relapsed/refractory myeloma. pPCL is a distinct clinicopathological entity with different cytogenetic and molecular findings. The clinical course is aggressive with short remissions and survival duration. We report two cases of pPCL, both having acute onset of illness, varied clinical presentation with one of them showing "hairy cell morphology," with rapidly progressing renal failure, and was not suspected to be plasma cell dyscrasia clinically. A detailed hematopathological evaluation clinched the diagnosis in this case. It is recommended that techniques such as immunophenotyping by flow cytometry and protein electrophoresis must be performed for confirmatory diagnosis. A detailed report of two cases and a review of PCL are presented here.
科研通智能强力驱动
Strongly Powered by AbleSci AI